STOM
- Aliases
-
- BND7
- EPB7
- EPB72
- Protein 7.2b
- STOM
- Stomatin
- erythrocyte band 7 integral membrane protein
- erythrocyte membrane protein band 7.2 (stomatin)
- erythrocyte surface protein band 7.2
- protein 7.2b
- stomatin
- Description
- STOM, or stomatin, is an integral membrane protein located in the cell membrane of red blood cells and other cell types, where it is thought to regulate ion channels and transporters. Multiple transcript variants are produced by alternative splicing.
Attributes
- QA State
- Curated
- Type
- Gene
- HGNC Name
- STOM
- Certifications
-
- None
- QA State for Breast
- Under Review
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
- Certifications
-
- None
- QA State for Prostate
- Under Review
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
- An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account.
- Development and validation of sandwich ELISA microarrays with minimal assay interference.
- Diagnosis of prostate cancer using differentially expressed genes in stroma.
- Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.
- Expression changes in the stroma of prostate cancer predict subsequent relapse.
- Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.